M&G Investment Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-150,457
Closed -$1.29K 424
2022
Q2
$1.29K Sell
150,457
-155
-0.1% -$2.17K 0.01% 327
2022
Q1
$3.49K Buy
150,612
+3,641
+2% +$89K 0.01% 273
2021
Q4
$4.07K Sell
146,971
-163
-0.1% -$4.36K 0.01% 269
2021
Q3
$4.06K Sell
147,134
-28,485
-16% -$808K 0.01% 437
2021
Q2
$5.1K Sell
175,619
-1,000
-0.6% -$30.3K 0.01% 396
2021
Q1
$5.62K Hold
176,619
0.02% 229
2020
Q4
$3.61K Buy
176,619
+19,839
+13% +$370K 0.02% 243
2020
Q3
$2.47M Sell
156,780
-96
-0.1% -$1.65K 0.02% 256
2020
Q2
$2.89M Sell
156,876
-44,837
-22% -$790K 0.03% 245
2020
Q1
$3.15M Buy
201,713
+3,124
+2% +$75.3K 0.04% 238
2019
Q4
$5.96M Buy
+198,589
New +$5.16M 0.05% 217

Other funds holding BHC

M&G Investment Management's BHC Position: Q3 2022 in Review

M&G Investment Management sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 150,457 shares — an estimated $1.29K sold.

M&G Investment Management first reported a position in BHC in Q4 2019 and held it in 11 quarters. The position peaked at $5.96M in Q4 2019. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • M&G Investment Management reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • M&G Investment Management sold 150,457 Bausch Health shares in Q3 2022, an estimated $1.29K.
  • M&G Investment Management first reported a position in Bausch Health in Q4 2019 and held it in 11 quarters.
  • M&G Investment Management's Bausch Health position peaked at $5.96M in Q4 2019.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on M&G Investment Management's 13F filing for Q3 2022, filed 1 Nov 2022.